Novadaq Technologies Inc. (NASDAQ:NVDQ)‘s stock had its “positive” rating restated by Wedbush in a note issued to investors on Tuesday.
A number of other equities analysts have also recently weighed in on NVDQ. JMP Securities assumed coverage on Novadaq Technologies in a report on Wednesday, June 1st. They issued a “mkt outperform” rating for the company. Zacks Investment Research cut Novadaq Technologies from a “buy” rating to a “hold” rating in a report on Wednesday, July 13th. Canaccord Genuity reaffirmed a “buy” rating and issued a $15.00 price target on shares of Novadaq Technologies in a report on Thursday, July 28th. Northland Securities reaffirmed an “underperform” rating and issued a $7.00 price target on shares of Novadaq Technologies in a report on Thursday, July 7th. Finally, Feltl & Co. raised Novadaq Technologies from a “buy” rating to a “strong-buy” rating in a report on Thursday, July 28th. Two equities research analysts have rated the stock with a sell rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $13.42.

Novadaq Technologies (NASDAQ:NVDQ) opened at 11.72 on Tuesday. Novadaq Technologies has a one year low of $8.26 and a one year high of $14.36. The company’s market capitalization is $673.14 million. The stock’s 50 day moving average price is $11.56 and its 200-day moving average price is $10.58.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/novadaq-technologies-inc-nvdq-given-positive-rating-at-wedbush.html

Novadaq Technologies (NASDAQ:NVDQ) last issued its quarterly earnings data on Wednesday, July 27th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.14) by $0.15. The company earned $20.12 million during the quarter, compared to analyst estimates of $19.97 million. Novadaq Technologies had a negative net margin of 49.45% and a negative return on equity of 25.28%. The business’s quarterly revenue was up 33.5% compared to the same quarter last year. During the same period last year, the firm earned ($0.22) EPS. Equities analysts forecast that Novadaq Technologies will post ($0.73) EPS for the current year.
Several large investors have recently bought and sold shares of NVDQ. Bank of New York Mellon Corp raised its stake in Novadaq Technologies by 14.3% in the second quarter. Bank of New York Mellon Corp now owns 41,529 shares of the company’s stock worth $407,000 after buying an additional 5,185 shares during the period. Bellevue Group AG bought a new stake in Novadaq Technologies during the first quarter worth about $2,994,000. Envestnet Asset Management Inc. raised its stake in Novadaq Technologies by 9.8% in the first quarter. Envestnet Asset Management Inc. now owns 19,154 shares of the company’s stock worth $212,000 after buying an additional 1,717 shares during the period. Geode Capital Management LLC raised its stake in Novadaq Technologies by 8.0% in the first quarter. Geode Capital Management LLC now owns 22,372 shares of the company’s stock worth $248,000 after buying an additional 1,665 shares during the period. Finally, Goldman Sachs Group Inc. raised its stake in Novadaq Technologies by 159.8% in the first quarter. Goldman Sachs Group Inc. now owns 343,073 shares of the company’s stock worth $3,805,000 after buying an additional 916,338 shares during the period. Institutional investors and hedge funds own 88.64% of the company’s stock.
Novadaq Technologies Company Profile
Novadaq Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.

Receive News & Ratings for Novadaq Technologies Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Novadaq Technologies Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.